This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Provention Bio, Inc., Yale University, Benaroya Research Institure at Virginia Mason. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rowayton, CT (US) (2018)
- Norwalk, CT (US) (2022 - 2024)
Company Filing History:
2 out of 3 
2 out of 1,365 
1 out of 1 Years Active: 2018-2024
Title: Kevan C. Herold: Innovator in Diabetes Prevention
Introduction
Kevan C. Herold is a prominent inventor based in Norwalk, CT (US), known for his significant contributions to the field of diabetes research. With a focus on preventing type 1 diabetes, he has developed innovative methods that aim to delay the onset of this chronic condition. His work has led to the issuance of three patents, showcasing his commitment to advancing medical science.
Latest Patents
Herold's latest patents include groundbreaking methods and compositions for preventing type 1 diabetes. One patent outlines a method that involves providing a non-diabetic subject at risk for type 1 diabetes and administering a prophylactically effective amount of an anti-CD3 antibody. This method also includes determining that the subject has a specific percentage of TIGIT+KLRG1+CD8+ T-cells, which indicates successful prevention or delay of the disease. Another patent focuses on identifying non-diabetic subjects who are free of antibodies against zinc transporter 8 (ZnT8) and have specific HLA types before administering the anti-CD3 antibody.
Career Highlights
Throughout his career, Kevan C. Herold has worked with notable organizations, including Provention Bio, Inc. and Yale University. His research has been pivotal in understanding the mechanisms behind type 1 diabetes and developing preventive strategies. His innovative approaches have garnered attention in the scientific community and have the potential to change the landscape of diabetes treatment.
Collaborations
Herold has collaborated with esteemed colleagues, including Francisco A. Leon and Jay S. Skyler. These partnerships have enriched his research and contributed to the advancement of diabetes prevention strategies.
Conclusion
Kevan C. Herold's work in diabetes prevention exemplifies the impact of innovative research on public health. His patents and collaborations highlight his dedication to finding solutions for type 1 diabetes, making him a significant figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile